📢 Don´t miss: The first results of the CLOSURE-AF (DZHK16) trial will be presented at the AHA Scientific Sessions 2025 on November 8, 2025. @dzhk_germany #AFNET #heart #afib #cardiotwitter

📢 Today is #WorldStrokeDay! #Stroke acts fast and you should too!! Every minute counts! 💪

We are excited to share that we’ve reached a significant milestone with 100 #patients successfully enrolled in the #EASThigh study! Recruitment is now open in 5 countries and we’re thrilled to see the study picking up speed! 🌍 A big thank you to all teams and supporters❣️💪

📢 UK clinicians — share your views! Dr Mokhtar Ibrahim (UHL NHS Trust) is surveying UK practice in anticoagulation for atrial high-rate episodes (AHRE) after ARTESIA & NOAH-AFNET 6. Takes 3–5 mins 👉 https://t.co/GRkCYEzm5q

Our #AFNET board member Prof. Dr. Andreas Goette for academic exchange in China! 🤩 🌎 👍

BEL’s order book is a cheat-sheet for how modern wars changed Phase 1 (FY18–20) - LRSAM/Akash, Integrated Air Command & Control, battlefield/coastal surveillance. Heavy-metal era. Phase 2 (FY21–22) - Command & Control, software-defined radios (SDR), AFNET/SATCOM, ship upgrades.

#MAESTRIA goes China! 🌎 Prof. Dr. A. Goette, leader of the MAESTRIA-AFNET 10 trial, presents this exciting EU-funded project during a series of scientific talks in China. 👍 #afib #AFNET #Cardiotwitter @H2020Maestria

The Networking Trap: Hidden Vulnerabilities in India’s ‘Network-Centric’ Air Strategy 🇮🇳✈️ India’s push toward a network-centric warfare (NCW) model — linking sensors, shooters, and decision-makers through advanced digital systems like AFNET & IACCS — has significantly

🎉 Successful start for #EASThigh at Deutsches Herzzentrum der Charité (DHZC)! We’re excited to share that the first 2 #patients have been successfully enrolled! 👏 Huge thanks to the dedicated team of PI Prof. Philipp Attanasio for your great engagement! @EKFStiftung @Medtronic

It is encouraging that a #cardiovascular health plan is being drawn up at European level. #AFNET took the chance to highlight the importance of research for #patients and to draw attention to the issue of #atrialfibrillation and #international research projects in the plan ❣️

【デバイス検出AFへのOACはWin-Ratio評価でも有用性証明できず： 　RCT “NOAH-AFNET 6” 追加解析/ EHJ QCCO [Sep 01]】 ・デバイス検出無症候性AF 2.534例 [平均77歳、 CHA2DS2-VASc中 　央値3]、21か月 [中央値] 観察： ・「死亡」「脳卒中」「塞栓症/MI」「大出血」の順で検討した DOAC

Early rhythm control in patients with atrial fibrillation? This trial showed rhythm control within a year of afib dx improved outcomes over rate control. Rationale? Reestablishing sinus rhythm BEFORE fibrillation-induced remodeling takes place.👇 EAST-AFNET 4 Trial, NEJM 2020 ♥️

📣速報📣 循環器ガイドライン フォーカスアップデート 本日公開されました！ 無症候性心房細動に対するカテーテルアブレーションはエビデンスが少なく今までClass IIb-Cでしたが、 EAST AFNET 4, CODE-AFの結果から、 無症候性 発作性 心房細動に対してCHADS-VASCスコア≧3点の条件付きで "Class

Top Clinical Trials of 2023: 1️⃣ LODESTAR 2️⃣ CLEAR Outcomes 3️⃣ BIOVASC 4️⃣ ELAN 5️⃣ NOAH-AFNET Read the details of the clinical trials here: https://t.co/7ZJWUjkVcs

Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial Findings suggest that #AF burden estimated by weekly short-term patient-operated ECGs modulates AF-related events on rhythm-control therapy https://t.co/tHIx3H7CIK

afnet, “coiffure royale”. On valide?

More recent trials such as EAST-AFNET 4 Trial (2020) are now shifting the paradigm to earlier rhythm control for newly diagnosed atrial fibrillation however 👇 Rationale? That maladaptive atrial remodeling with afib leads to more afib … afib begets afib

MCT-LSV Mobile Communication Terminal Features: 1. IP Centric with AFNET Integration 2. Multi Layer Communication (Satcom, VHF, LOS, OFC) 3. SOTM & ROTM as Optional Feature 4. IP Centric– Voice/Data/Video 5. Data Security with NGFW & BEU 6. Air Transportable for Quick Deployment

Post-Balakot, IAF quietly did what theorists thought impossible. A phased SDR upgrade spree across Su-30MKI, Mirage-2000I, LCA, Mig29, Rafale, Netra, AWACS, and AFNet nodes on SAM and Radars. Multi-band, crypto-agile, TDL-capable SDRs now hum in sync. Homogeneous, jam-resistant,